In the press

Matthew Read comments on CYN and GPM manager resignations in Investment Week

Biotech trusts top performance charts in February

Matthew Read comments on the resignations of the CYN and GPM managers in Michael Nelson’s article:

“Shareholders in all the funds affected will be looking for clarity about each fund’s plans. The good news is that Watson and Crayfourd will continue to manage the portfolios for the next three months and, given that this is an evolving situation, we would suggest shareholders sit tight and see what happens,”

Read the article here: